Familial amyloidosis causes: Difference between revisions
Jump to navigation
Jump to search
No edit summary |
No edit summary |
||
| (3 intermediate revisions by 2 users not shown) | |||
| Line 1: | Line 1: | ||
__NOTOC__ | __NOTOC__ | ||
{{Familial amyloidosis}} | {{Familial amyloidosis}} | ||
{{CMG}}; {{AE}} | {{CMG}}; {{AE}} {{Fs}} | ||
== Overview == | == Overview == | ||
Hereditary amyloidosis can be caused by [[genetic mutations]] in | Hereditary amyloidosis can be caused by [[genetic mutations]] in [[genes]] encoding [[Transthyretin amyloidosis|transthyretin]], [[Apolipoprotein AI amyloidosis|apolipoprotein AI]], [[Apolipoprotein AII amyloidosis|apolipoprotein AII]], [[Lysozyme amyloidosis|Lysozyme]], [[Gelsolin related amyloidosis|gelsolin]], [[Fibrinogen A alpha chain amyloidosis|fibrinogen Aa-chain]], and [[Cystatin C amyloidosis|cystatin C]]. | ||
==Causes== | ==Causes== | ||
Latest revision as of 19:11, 7 February 2020
|
Familial amyloidosis Microchapters |
|
Diagnosis |
|---|
|
Treatment |
|
Case Studies |
|
Familial amyloidosis causes On the Web |
|
American Roentgen Ray Society Images of Familial amyloidosis causes |
|
Risk calculators and risk factors for Familial amyloidosis causes |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Fahimeh Shojaei, M.D.
Overview
Hereditary amyloidosis can be caused by genetic mutations in genes encoding transthyretin, apolipoprotein AI, apolipoprotein AII, Lysozyme, gelsolin, fibrinogen Aa-chain, and cystatin C.
Causes
Common Causes
Common causes of familial amyloidosis may include genetic mutations in:[1][2][3][4]
- Transthyretin (TTR)
- Apolipoprotein AI
- Apolipoprotein AII
- Fibrinogen Aa
- Lysozyme
- Gelsolin
- Cystatin C
References
- ↑ Pepys MB, Hawkins PN, Booth DR, Vigushin DM, Tennent GA, Soutar AK, Totty N, Nguyen O, Blake CC, Terry CJ (April 1993). "Human lysozyme gene mutations cause hereditary systemic amyloidosis". Nature. 362 (6420): 553–7. doi:10.1038/362553a0. PMID 8464497.
- ↑ Benson, Merrill D (2003). "The hereditary amyloidoses". Best Practice & Research Clinical Rheumatology. 17 (6): 909–927. doi:10.1016/j.berh.2003.09.001. ISSN 1521-6942.
- ↑ Benson, Merrill D (2003). "The hereditary amyloidoses". Best Practice & Research Clinical Rheumatology. 17 (6): 909–927. doi:10.1016/j.berh.2003.09.001. ISSN 1521-6942.
- ↑ Scriver, Charles (2001). The metabolic & molecular bases of inherited disease. New York: McGraw-Hill. ISBN 978-0079130358.